Publications

Pundole X, Ju C-H, Bylsma LC, Hooda N, Movva N, Elkhouly E, Bebb DG, Fryzek J, et al. 2023. Prevalence of delta-like ligand 3 expression in small cell lung cancer. J Clin Oncol 41(16_suppl):e20618; doi: 10.1200/JCO.2023.41.16_suppl.e20618.

Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr P, Sawyer E, Stephen CD, Eichler F. Healthcare utilization, burden of illness, and mortality in adults with adrenomyeloneuropathy: The case for genetic therapies. Poster presentation, American Society of Cell and Gene Therapy Meeting, Los Angeles, CA, May 2023.

Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr P, Sawyer E, Stephen CD, Eichler F. Substantial burden of illness and mortality in men with adrenomyeloneuropathy. Poster presentation at American Academy of Neurology Annual Meeting, April 2023.

Minshall M, Emden M, McLin R, Kemp P, Pontenani F, Cardosi L, Sacks N. The cost of non-cystic fibrosis bronchiectasis (NCFB) in patients with commercial insurance or Medicare coverage in the US. Poster presentation, ISPOR, April 2023.

Eichler F, Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr P, Sawyer E, Stephen C. The economic impact of adrenomyeloneuropathy (AMN) on direct medical costs in commercially insured US adults: A retrospective study. Poster presentation, ISPOR 27th International Meeting, Boston, MA, April 2023.

Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr P, Sawyer E, Stephen C. Hospitalizations, clinical characteristics and mortality in adults with adrenomyeloneuropathy (AMN): A retrospective study. Poster presentation, ISPOR 27th International Meeting, Boston, MA, April 2023.

Wood CT, Walter E, Espinosa CM, Enriquez-Bruce ME, Budhecha S, Elliott A, Domachowske J,…, Suh M, et al. Seasonality of infant lower respiratory tract infections, including those caused by RSV, was altered during the COVID-19 pandemic: Results from four US health systems. Poster #642 at the Pediatric Academic Societies Meeting, Washington, DC, April 2023.

Suh M, Reichert H, Jiang X, Pastula ST, Movva N, Fryzek J, Simoes E. The burden of RSV and bronchiolitis in the US infant Medicaid population extends beyond the inpatient setting. Oral presentation to the Pediatric Academic Societies Meeting, Washington, DC, April 2023.

Pang F, Dean R, Jensen I, Bean K, Fields C, Miller B. 2023. The cost-effectiveness of OTL-200 for the treatment of metachromatic leukodystrophy (MLD) in the US. Mol Gene Metab 138(2):107258; doi: 10.1016/j.ymgme.2022.107258.

Wood CW, Walter E, Espinosa C, Enriquez-Bruce ME, Budhecha S, Elliott A, Domachowske J,…, Suh M, et al. Results from four US health systems: (1) Seasonality of infant lower respiratory tract infections, including those caused by RSV, was altered during the COVID-19 pandemic; and (2) Infant hospitalizations and ICU admissions for bronchiolitis and RSV-bronchiolitis are at historic highs during 2022 early seasonal disease. Companion posters presented at the 7^th ReSViNET Conference, Respiratory Syncytial Virus Foundation, Lisbon, Portugal, February 2023.